Work

21LBA Atezolizumab in patients (pts) with locally-advanced or metastatic urothelial carcinoma (mUC): Results from a pivotal multicenter phase II study (IMvigor 210)

Year: 2015

Type: article

Source: European Journal of Cancer

DOI: 10.1016/s0959-8049(16)31942-6

Authors: J. Rosenberg, D. Petrylak, O. Abidoye, M.S. Van der Heijden, J. Hofman-Censits, A. Necchi, P.H. O'Donnell, A. Balmanoukian, Y. Loriot, M. Retz, J.L. Perez-Gracia, N.A. Dawson, A. Balar, M.D. Galsky, M.T. Fleming, T. Powles, N. Cui, S. Mariathasan, G.D. Fine, R. Dreicer

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2470163336

FWCI: 3.572

Cites:

Cited by: 14

Related to: 10